Hair Transplant for Women: Who It Suits and Who It Does Not

Medically reviewed by Dr Ahmet Dilber, Consultant Plastic, Reconstructive and Aesthetic Surgeon — 18 August 2026

What a hair transplant for women involves

A hair transplant for women moves follicular units from the permanent donor area at the back and sides of the scalp into thinned regions. The surgical sequence is the same as any hair transplant: grafts are removed individually with the FUE technique, recipient sites are opened at a planned angle and direction, and the grafts are placed. What differs is who it is offered to, where the grafts go, and how much is shaved.

In practice the commonest requests are a front hairline that has crept back or was always high, a part line that has widened, temples that have thinned, and camouflage of a scar — most often the incision left by a surgical forehead reduction, sometimes a facelift scar. These are different problems with different graft counts and different answers, and they are treated separately further down this page.

The part that matters most, though, comes before any of it. A hair transplant for women only works where the donor area is stable, and in women that is a real question rather than a formality.

How female hair loss behaves, and why the hairline usually survives

The condition behind most requests for a hair transplant for women is female pattern hair loss: a non-scarring, progressive condition in which the ratio of thick terminal hairs to short, fine vellus hairs falls — a process called follicular miniaturisation. The follicle does not die at once; it shrinks, and each cycle produces a shorter, thinner, lighter hair until it produces none. Roughly 40% of women show signs of hair loss by the age of 50.

The pattern is usually diffuse rather than bald patches, and it concentrates on the crown and along the part line. Three descriptive systems are in use and they measure different things, which is why a woman can be told different grades by different clinics without either being wrong.

The frontal hairline usually survives, and there is a measurable reason for it. In women, frontal follicles carry roughly three to three and a half times less 5α-reductase than in men, while aromatase content in frontal hair is around six times higher. Aromatase converts testosterone to oestradiol, which removes substrate from the pathway that produces DHT. Less of the enzyme that makes DHT, more of the enzyme that diverts its precursor — so the front line miniaturises far less than it does in men.

That single fact shapes a hair transplant for women. A woman who keeps her frontal hairline needs density behind it rather than a new line in front of it, and a woman who has lost her frontal hairline needs a diagnosis before she needs a plan, because in women that is not the typical pattern.

Causes of female hair loss that surgery does not solve

This is the section most pages about a hair transplant for women leave out, and it is the one that decides whether surgery helps. Several conditions produce thinning that looks similar in the mirror. They do not behave similarly once grafts are placed.

The rule underneath a hair transplant for women is simple: hair loss has to be stable before it can be transplanted. Where loss is still active or progressing quickly, medical management is used first, typically for six to twelve months, and the assessment is repeated. Operating into an unstable process spends donor hair to chase a line that is still moving.

Diffuse unpatterned loss

Diffuse loss comes in two forms, and before any hair transplant for women is planned they have to be told apart; and telling them apart is the single most important measurement in a hair transplant for women.

In diffuse patterned alopecia the top, front and crown thin while the back and sides stay stable. There is a permanent zone to harvest from, and surgery can work. In diffuse unpatterned alopecia the miniaturisation runs across the entire scalp — temporal, parietal and occipital included. There is no stable permanent zone, and transplantation is contraindicated.

The reason this matters so much in women is a figure that rarely appears on clinic pages. The professional society’s own review of donor densitometry reports that the unpatterned form is much more common in women, possibly occurring ten times as frequently as the patterned form, and concludes that a far smaller percentage of women are good candidates for surgery than men. That is not a reason to discourage women from asking. It is the reason the donor area is measured rather than glanced at.

Where the donor is already miniaturising, harvesting from it makes the visible thinning there worse, and the transplanted follicles carry the same tendency with them — they can continue to miniaturise in their new position. The result is a patient who has paid for a procedure, lost donor density, and gained nothing that lasts.

Frontal fibrosing alopecia

Frontal fibrosing alopecia deserves its own section in any page about a hair transplant for women because it is the condition most often mistaken for an ordinary receding hairline in women, and because acting on that mistake is expensive and irreversible.

It is a patterned scarring hair loss along the frontal margin. The band of recession is usually smooth and pale, the skin looks slightly different from the forehead beside it, and there are clues that an ordinary recession does not produce. Incidence is reported to be increasing worldwide; one recent review describes it as an emerging problem in hair pathology. It was first described in postmenopausal women and is still commonest there, but younger women, men and children are now reported too.

In a scarring alopecia the follicle is destroyed and replaced by fibrous tissue. Grafts placed into an active process meet the same process. Where frontal fibrosing alopecia is suspected, the referral is to dermatology for diagnosis, treatment aims at stopping the activity, and surgery is only reconsidered after a prolonged quiet period — if at all.

• A band of recession that looks smooth and pale rather than simply thinner
• Loss or thinning of the eyebrows, often before the hairline changes
• Redness or fine scaling around individual follicles at the receding edge
• A single hair left standing in front of the new margin — the “lonely hair” sign
• Itching, burning or tenderness along the front hairline
• Loss of the fine hairs that normally soften the edge of the hairline

Which tests are needed

The blood work before a hair transplant for women is shorter than most people expect, and shorter than many clinics order.

In any woman with diffuse hair loss, serum ferritin and thyroid function are the two tests that guidance agrees on. Ferritin matters because iron deficiency is a well-supported driver of telogen effluvium: below 30 µg/L the odds of telogen effluvium rise sharply, and below 40 µg/L is treated as an indicator of deficiency worth correcting when symptoms fit. Worth being precise, though — the evidence linking low iron to pattern hair loss is insufficient, and one large study found no increase in iron deficiency in female pattern loss compared with controls. Ferritin is checked because effluvium has to be excluded, not because iron explains genetic thinning.

Hormone testing is targeted rather than routine. Where there is irregular menstruation, difficulty conceiving, excess body hair, treatment-resistant cystic acne or other signs of androgen excess, an endocrine work-up is appropriate — and polycystic ovary syndrome is considered. Where those features are absent, most women tested have normal androgen levels, and the panel adds cost rather than information.

• Ferritin — to exclude iron-related effluvium, not to explain pattern loss
• Thyroid function — recommended in all diffuse hair loss
• Full blood count — standard pre-operative work
• Targeted hormone panel — only where signs of androgen excess are present
• Vitamin D and zinc — not routinely recommended by dermatology guidance for pattern hair loss; tested where there is a separate clinical reason
• Trichoscopy of the donor and recipient areas — the measurement that actually decides candidacy

Pregnancy, postpartum, menopause

Hair loss around childbirth follows a predictable curve, and it changes the timing of a hair transplant for women. During pregnancy hormonal changes hold follicles in the growing phase; after delivery that support is withdrawn and a large cohort enters the resting phase together. Shedding peaks around six to eight weeks after delivery and settles over the following months. A hair transplant is not planned during pregnancy or breastfeeding, and it is not planned during an active postpartum effluvium, because the loss is neither permanent nor stable.

One finding is worth knowing before assuming postpartum shedding will simply pass. In a series of 200 postpartum women, isolated telogen effluvium accounted for under one in ten. In just over half, effluvium sat on top of female pattern hair loss; in around a quarter, effluvium, pattern loss and traction alopecia were present together. Postpartum shedding often unmasks something that was already there, which is why trichoscopy is worth doing rather than waiting a year to see.

After menopause the picture shifts again: incidence of pattern loss rises, and one small cross-sectional study of postmenopausal women found pattern loss in just over half of them. It is also the group in which frontal fibrosing alopecia was originally described, so a receding front margin in a postmenopausal woman is examined for that before it is planned as a hairline case.

Medical treatment first

Medical treatment is not an alternative offered instead of a hair transplant for women; in women it is usually the step that comes first, and often the step that makes surgery unnecessary or possible.

Topical minoxidil is the mainstay with the clearest evidence in women. A phase III trial in 322 women compared 5% foam once daily with 2% solution twice daily and measured almost the same result at 24 weeks — about 24 hairs per cm² gained in each arm, a difference of 0.3 hairs in favour of the solution. One detail is usually left out when this trial is quoted: the study’s formal non-inferiority test failed, because the confidence interval around that difference was wider than the margin set in advance. What the trial establishes is that both regimens work and both are well tolerated; what it does not establish is that the once-daily foam is equivalent to the twice-daily solution. Which one suits a particular woman — and whether she will actually use it twice a day — is a decision for the treating physician.

Other options are considered by the treating physician according to the diagnosis and to whether pregnancy is possible. One point is not a matter of preference: finasteride is contraindicated in women who are or may become pregnant, because of the risk of a specific malformation in a male fetus. Any decision about hormonal or anti-androgen treatment belongs to the prescribing physician, and where a woman is already on medication, nothing is stopped on her own initiative — the prescribing doctor and the Hair of Istanbul medical team plan it together.

Where surgery does go ahead, medical treatment usually continues alongside it. The grafts are permanent; the hair around them is not, and thinning that continues around a transplanted zone is what makes a good early result look worse at year three.

Who is a candidate for a hair transplant for women?

Candidacy for a hair transplant for women rests on three questions: is the loss stable, is the donor area capable of supplying what the recipient needs, and is the diagnosis certain. The third is the one that most often changes the answer.

Assessment includes trichoscopy of both the thinned area and the occipital scalp, a written donor map with density and miniaturisation recorded, the blood work above, and — where the pattern is not clearly female pattern loss — referral for dermatological diagnosis before any surgical date is discussed.

Usually suitable

• Stable female pattern loss with a measured donor density in the safe range
• A high or receded front hairline where the donor is unaffected
• A widened part line with adequate density behind it
• Permanent gaps from traction alopecia, once the causative styling has stopped
• A scar from surgical hairline lowering or from a facelift, once the tissue is settled
• Realistic expectations set against donor supply rather than the size of the thin area

Needs assessment or treatment first

• Shedding that started within the last six months, or is still increasing
• Thinning that includes the back and sides — the donor area itself
• A receding front margin with eyebrow loss or redness around the follicles
• Pregnancy, breastfeeding, or an active postpartum effluvium
• Any scarring alopecia that has not been quiet for a prolonged period
• Diffuse loss without a clear pattern, which needs a diagnosis before a plan
• Styling that still puts the hairline under tension

What is treated surgically

Where a woman is a candidate, a hair transplant for women usually addresses one of four situations. They are worth separating because the graft numbers, the design and the realistic result are different in each.

The first is the front hairline — either naturally high or receded, and treated by bringing the line forward with grafts. The second is scar camouflage, most often the incision left by a surgical forehead reduction. The third is traction alopecia. The fourth, and the commonest reason women come, is density behind an intact hairline: a widened part line or thinning at the crown, where the aim is to thicken what is already there rather than to draw a new edge.

That fourth situation is also the one where candidacy is most often declined, because it is the presentation most likely to be diffuse loss involving the donor.

Lowering a high hairline

A high or receded front hairline is the clearest indication in a hair transplant for women, because the target is definable and the donor is usually unaffected.

Two different operations lower a hairline in a hair transplant for women and they should not be confused. Grafting moves follicular units into the area in front of the existing line; published practice reports 800 to as many as 2,800 follicular unit grafts, with refinement sessions of 300 to 800, and a lowering of roughly one to three centimetres at the front. Surgical advancement, by contrast, moves the scalp itself forward and is a different procedure with a different recovery and a permanent incision line; it requires a scalp that can be pushed forward by hand by 1.3 cm or more, and the published average is about 2.1 cm, with 5–5.5 cm reached only in exceptional candidates.

Hair of Istanbul lowers hairlines with grafts, not by advancing the scalp. The forehead reduction page sets out that approach in full. Where a woman has already had surgical advancement elsewhere and wants the incision softened, that is a scar camouflage case — the next section.

Scar camouflage

Camouflaging a scar with grafts is one of the most useful things a hair transplant for women can do, and one of the least predictable. Both halves of that sentence matter.

The commonest case is the incision left by surgical hairline lowering, also called scalp advancement. The line sits exactly where hair should begin, so it is visible whenever the hair is pulled back. In published surgical-advancement practice, 400 to 1,600 grafts are placed to round out and soften that hairline, and grafting can begin as early as three to four months after the original surgery. Facelift scars at the temples are approached the same way. In a prospective series of 33 women treated for scarring and displaced hairlines after a facelift, 31 were assessed at follow-up: 24 rated the correction excellent, 4 satisfactory and 3 unsatisfactory.

The unpredictable half of a hair transplant for women placed into scar tissue is graft survival. Scar tissue carries a poorer blood supply than healthy scalp, and that supply varies between patients and even between parts of the same scar. There is no honest single percentage to quote, and any clinic that quotes one is quoting nothing. What the literature does give is a way of handling the uncertainty: place fewer grafts per square centimetre where perfusion is doubtful — around 15 to 20 follicular units per cm², against 20 to 30 where it is good — and, in difficult cases, place a small test area first and judge it before committing the rest of the donor.

Traction alopecia

Traction alopecia is loss caused by sustained pull on the roots — tight ponytails, braids, weaves, extensions and buns, and it is often combined with chemical processing. It usually shows as a band of loss just behind the front margin, and in many women a narrow strip of hair is retained at the very edge, which means the area needing grafts sits behind the visible hairline rather than in front of it.

Early on the follicle is only irritated and hair returns in full once the pull stops. If the pull continues, follicles are replaced by fibrous tissue and the loss becomes permanent. There is no published threshold for when that crossing happens, and any specific figure quoted for it is invented.

The order before a hair transplant for women is fixed: the styling stops first, spontaneous regrowth is allowed to complete, and only the areas that do not return are transplanted. Where the styling will continue afterwards, the same mechanism will act on the transplanted follicles, and surgery is not the right answer. The simplest test there is: if a style hurts while it is being done, it is causing damage.

Shaving: what is trimmed

How much hair is shaved before a hair transplant for women is the question asked first, and it has a precise answer.

The recipient area is not shaved. Grafts are placed between the existing hairs, which is technically more demanding than working on a shaved field but avoids the one thing most women will not accept. In the donor area a band is trimmed — the strip the grafts are taken from — and the hair growing above it falls over that band and covers it from the day of surgery. Nothing needs to grow back before the area is presentable; it is hidden by length, not by regrowth. For reference, hair grows at roughly a third of a millimetre a day, about a centimetre a month, so the trimmed band itself takes some months to catch up — which is exactly why it is positioned to be covered rather than left to regrow.

The terminology here is worth getting right, because clinic marketing has produced several names for the same thing. The professional society’s own guidance describes the donor area as fully shaved, partially shaved or left unshaven, and asks clinics to state plainly which stage — donor, recipient or both — they mean when they advertise an unshaven procedure. Names such as “U-FUE”, “hidden window” and “non-shaven DHI” are marketing labels rather than terms from the literature. One of them is worse than merely invented: in the literature, “window” describes a complication — a thinned patch left in an over-harvested donor area.

Long-hair FUE, honestly

Long-hair FUE — taking and placing grafts with the hair still at full length — is one way to perform a hair transplant for women, and it is worth an honest paragraph, because it is marketed on a promise it does not keep.

The promise is that the result is visible immediately. It is — for a few weeks. The transplanted hairs shed between two and eight weeks after surgery, exactly as they do after any transplant, and the multi-surgeon series that reports the largest long-hair experience states outright that informed consent must emphasise that shedding. The same series records a mean shaft breakage rate of 12%, meaning a long-shafted graft was retrieved 88% of the time, so even the temporary preview does not cover every graft. No published data show a better final result than a shaved or partially shaved procedure.

What the technique genuinely offers is different and less dramatic. It covers the recipient area for the month or two before shedding, which matters to someone who cannot take time away. It allows the direction and curl of each hair to be seen while it is placed, which is a real technical advantage. And it allows density to be judged visually during the operation rather than by count alone.

The cost is capacity. Working through long hair makes the exit angle harder to read, and the published transection figures vary widely with the operator and the instrument: 9.2% in one single-operator series of 134 patients, 4.6% in a five-surgeon series using a purpose-built device, against a threshold of about 5% commonly quoted for shaved work. No controlled trial has compared long-hair and shaved harvesting directly, so no multiple should be claimed in either direction. Session sizes are smaller: the reported means run from about 840 grafts per patient in the larger series to roughly 1,200 in female hairline cases. Long-hair FUE is therefore offered for selected cases rather than as the default, and the trade is explained before it is chosen, not after.

The donor area

The donor area does two jobs in a hair transplant for women: it supplies the grafts, and it decides whether there should be an operation at all. The second job is covered above; this is the first.

Grafts are taken from the occipital scalp, within the zone that is genetically least affected by pattern loss. The band is planned so that the hair above it covers it, and harvest is spread across the area rather than concentrated, which is what prevents the thinned patch that over-harvesting leaves behind. Density is recorded region by region before extraction begins, and where a region reads low, fewer grafts are taken from it.

This restraint costs something in a single session and saves the option of a second one. Female hair loss is progressive; a woman who has a transplant at 40 may want another at 50, and a donor area that was emptied to maximise the first result cannot supply the second.

Graft numbers

Most sessions in a hair transplant for women place between 1,500 and 2,500 grafts. That range reflects what the common indications actually need rather than a package size: a front hairline, a part line or a scar are smaller targets than a bald crown.

In a hair transplant for women the number is set by what the donor can give without visible thinning, not by the area a patient wants covered. A figure quoted before the donor area has been examined under magnification is a guess, and in women it is the guess most likely to be wrong, because the donor is the variable.

The day of the procedure

A hair transplant for women runs for six to eight hours in one day under local anaesthesia. Blood tests are taken beforehand and reviewed by the medical team, and the hairline or the target area is drawn and agreed with the patient before anything is trimmed.

The donor band is trimmed and covered; the recipient area is left as it is. Grafts are removed individually, then placed either with forceps into pre-made sites or with the DHI technique, depending on the area and on how much existing hair has to be worked around. Placing between existing hairs is slower than placing into a shaved field, and the session is planned for that.

Breaks are taken through the day. For patients travelling to Turkey, the operation is preceded by an in-person assessment at the clinic in Istanbul and followed by an examination before departure, and the aftercare routine and the first wash are demonstrated in person rather than handed over as a leaflet.

Shock shedding

Shock shedding is the temporary loss of existing hairs around newly placed grafts, and it needs a straight explanation in any page about a hair transplant for women, because women are more exposed to it than men.

The reason is arithmetic rather than biology. In men the recipient area is often already bald, so there is nothing to shed. In women grafts are usually placed among hairs that are still there, and some of those hairs respond to the disturbance by entering the resting phase early. A review of FUE complications puts the reported incidence across all patients at anywhere from 0.15% to 15%, beginning two to eight weeks after surgery with regrowth over roughly three months — and lists female sex and female pattern hair loss among the risk factors.

It is temporary in the great majority of cases. The situation where it is not is the one already described: where the hairs surrounding the grafts were themselves heavily miniaturised, they may not return. That is why recipient miniaturisation is measured beforehand and why density is planned conservatively in a field of existing hair.

• Typically begins two to eight weeks after surgery and recovers over about three months
• More likely where recipient hairs are already miniaturised — measured beforehand
• Reduced by conservative implantation density and by limiting tumescent volume
• Managed with reassurance and, where the physician advises, topical or oral minoxidil
• Discussed before surgery rather than explained afterwards

Recovery timeline

The timeline for a hair transplant for women matches any hair transplant. What differs is visibility: because the surrounding hair is longer and was never shaved, each stage is less obvious to everyone else, and often less obvious to the patient too.

A hair transplant for women is judged at 13 to 15 months. Comparison photographs are taken in the same lighting, at the same angle and with the hair prepared the same way, because in a field of existing hair a difference in parting or lighting can look like a difference in density.

Aftercare

Aftercare following a hair transplant for women is the same protocol as any hair transplant at Hair of Istanbul, and the after care page sets it out day by day. The first wash is performed at the clinic before departure and demonstrated in person; after that the follow-up continues from home, with photographs reviewed by the medical team at the scheduled intervals.

Two points are worth repeating here because they come up more often in women. Long hair must not be tied back, clipped or put under any tension while the grafts are healing — the reflex to pull it away from the working area is exactly the mechanical force that traction alopecia is made of. And combing or detangling waits until the crusting phase is over, because long hair catches on crusts and a pulled crust before day nine takes the graft with it.

Price

A hair transplant for women in Turkey is priced on the same graft packages as any hair transplant at Hair of Istanbul — €4,000–€5,000, according to the number of grafts planned. Working around existing hair takes longer than working on a shaved field; that additional time is not charged separately, and the band on the pricing page is the one that applies.

The price covers the pre-operative assessment and blood tests, the procedure under local anaesthesia, the aftercare set, the first wash at the clinic and the follow-up schedule. Patients travelling to Istanbul should plan three days in the city: assessment and surgery, the first wash, and an examination before departure.

What a particular case needs is settled by examination — in person or from photographs, with trichoscopy of the donor area. Ask for an assessment and both the plan and the graft number follow from what it finds; a number offered before that is not a quotation, it is a guess.

Frequently asked questions

Sources

The clinical claims on this page are drawn from the sources below. Where a figure comes from a small series or a single study, that is stated in the text rather than rounded into a general fact.

1. Bernstein RM, Rassman WR. Follicular transplantation: patient evaluation and surgical planning. Dermatol Surg 1997;23(9):771–784. https://pubmed.ncbi.nlm.nih.gov/9311372/
2. Densitometry and video-microscopy. Hair Transplant Forum International 2007;17(2):41. https://www.ishrs-htforum.org/content/17/2/41
3. Female pattern hair loss. DermNet. https://dermnetnz.org/topics/female-pattern-hair-loss
4. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol 2015;90(4):529–543. https://pmc.ncbi.nlm.nih.gov/articles/PMC4560543/
5. Androgenetic alopecia. StatPearls, NIH Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK430924/
6. Hair transplantation. StatPearls, NIH Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK547740/
7. Telogen effluvium. DermNet. https://dermnetnz.org/topics/telogen-effluvium
8. Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician 2009;80(4):356–362. https://www.aafp.org/pubs/afp/issues/2009/0815/p356.html
9. Frontal fibrosing alopecia. DermNet. https://dermnetnz.org/topics/frontal-fibrosing-alopecia
10. Frontal fibrosing alopecia: a comprehensive guide for cosmetic dermatologists. Dermatol Ther (Heidelb) 2024. https://link.springer.com/article/10.1007/s13555-024-01311-z
11. Postpartum telogen effluvium unmasking additional latent hair loss disorders. J Clin Aesthet Dermatol 2024;17(5):15. https://jcadonline.com/1941-2789-17-5-15/
12. Blume-Peytavi U et al. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss. J Drugs Dermatol 2016;15(7):883–889. https://pubmed.ncbi.nlm.nih.gov/27391640/
13. Finasteride. DermNet. https://dermnetnz.org/topics/finasteride
14. Lowering the female hairline: two options in treatment. Hair Transplant Forum International 2013;23(1):12. https://www.ishrs-htforum.org/content/23/1/12
15. Surgical hairline advancement: patient candidacy and best techniques. Hair Transplant Forum International 2018;28(5):184. https://www.ishrs-htforum.org/content/28/5/184
16. Role of hair transplantation in scarring alopecia — to do or not to do. Indian J Plast Surg 2021;54(4):501–506. https://pmc.ncbi.nlm.nih.gov/articles/PMC8719951/
17. Follicular transplantation for the correction of various stigmas after rhytidoplasty. Aesthetic Plast Surg 2007;31(1):62–68. https://link.springer.com/article/10.1007/s00266-006-0141-5
18. Hair loss: female pattern. British Association of Dermatologists patient information leaflet, 2024. https://cdn.bad.org.uk/uploads/2021/11/25160409/Hair-loss-female-pattern-PIL-Oct-24.pdf
19. Hairstyles that pull can cause hair loss. American Academy of Dermatology. https://www.aad.org/public/diseases/hair-loss/causes/hairstyles
20. Park JH, You SH, Kim NR, Ho YH. Long hair follicular unit excision: personal experience. Int J Dermatol 2021;60(10):1288–1295. https://pubmed.ncbi.nlm.nih.gov/34029384/
21. Umar S et al. No-shave long hair follicular unit excision using an all-purpose skin-responsive device. Clin Cosmet Investig Dermatol 2023;16:3681–3691. https://pmc.ncbi.nlm.nih.gov/articles/PMC10746190/
22. Shaven and un-shaven hair transplant terminology. ISHRS. https://ishrs.org/unshaven-and-shaven-hair-transplant-terminology/

Related pages

Pages that cover the techniques, the aftercare and the related procedures referred to above.